These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%We are living in times when the morning may see conciliatory exchanges between the US and Iran, leading to a cooling in crude oil prices. B...
04 May, 2026, 11.04 PM IST
ET Prime Special Series: Multibagger or Bankrupt - Part 56: An acquisition, a divestment, and a JV for EV. Ready for re-rating?Bulls argue this company is becoming a complete mobility-platform supplier in India: Power solutions and aftermarket, braking and safety. B...
29 Apr, 2026, 09.24 PM IST
India to attract major share of EQT's $15.6-billion Asia fund: EQT India headEQT expects India to remain a top capital destination in its new Asia fund, with roughly one-third allocation historically. The firm sees s...
21 Apr, 2026, 08.49 PM IST
Fortis Healthcare gets CCI nod to acquire additional stake in Agilus Diagnostics for Rs 1,780 crThe Competition Commission of India (CCI) has approved Fortis Healthcare's acquisition of an additional 31.52% stake in Agilus Diagnostics,...
29 Oct, 2024, 08.53 PM IST
GSK Velu in talks with investors, PEs & banking firms to buy Metropolis Healthcare stakeMetropolis chief executive Ameera Shah and her family has initiated a formal process to sell part of the promoter stake and is understood t...
13 Jun, 2022, 06.11 PM IST
Motilal Oswal Private Equity invests RS 194.4 crore in Pathkind DiagnosticsEstablished in 2016, Pathkind is one of the fastest growing diagnostics services chains in India with a network of over 75 labs of which 13...
20 May, 2022, 07.46 PM IST
Amazon, Walmart's Flipkart in talks to buy stake in $1.1 billion diagnostics chain Metropolis HealthcareThe company is in early discussions with several global strategic investors and other potential purchasers of the shares, said the people, ...
20 May, 2022, 03.36 PM IST
Metropolis Healthcare up 0.7% as board approves acquisition of Hitech DiagnosticMetropolis Healthcare said the deal would be worth Rs 636 crore.
18 Oct, 2021, 11.49 AM IST
Diagnostics chain HealthMaP looks at merger with iGeneticUnder the proposed deal, HealthMap will get access to iGenetic’s core markets in Mumbai and other profit-making regions. “The idea is to me...
06 Apr, 2021, 11.10 AM IST
Constellation Alpha to acquire pathology chain Medall HealthcareConstellation was formed as a public platform for acquiring Indian healthcare businesses. Constellation raised $144 million in its initial ...
03 Aug, 2018, 12.55 PM IST
OrbiMed to invest $40 million in Suraksha DiagnosticsSuraksha, promoted by Panorama Group, operates more than 30 centres including polyclinics and has expanded services to include cardiology ,...
17 Nov, 2016, 11.35 AM IST
Carlyle to buy 37% stake in diagnostics chain MetropolisGlobal private equity fund Carlyle is buying 37% stake in diagnostics chain Metropolis from one of its founders GSK Velu.
10 Sep, 2015, 03.16 AM IST
Carlyle may end Metropolis feud with Rs 900 crore stake buyMetropolis s today a multinational chain with more than 125 laboratories, tracking Rs 600-crore revenue annually.
02 Jul, 2015, 12.16 PM IST
- Fortis to acquire 86% stake in Super Religare Laboratories
Billionaire brothers Malvinder and Shivinder Singh are selling 86% stake in Super Religare Laboratories ahead of its public issue, to liste...
15 Apr, 2011, 04.44 AM IST
- Singh bros may buy Piramal’s 10% in SRL ahead of public issue
The promoters of Super Religare Laboratories Malvinder and Shivinder Singh may buyout Piramal Heathcare’s 10% stake in the country’s larges...
25 Oct, 2010, 02.33 AM IST
- US PE firm in talks to buy 15% in Dr Lal PathLabs from Sequoia
US-based private equity (PE) firm TA Associates is in advanced talks to buy half of Sequoia Capital’s 30% stake in the country’s largest di...
16 Aug, 2010, 02.32 AM IST
- SRL in talks to acquire Piramal Diagnostics
Diagnostic chain Super Religare Laboratories is in advanced talks to buy Piramal Healthcare’s diagnostic chain for up to Rs 800 crore.
12 Jul, 2010, 06.44 AM IST